These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 10613826)

  • 1. Glutamate excitotoxicity in a model of multiple sclerosis.
    Pitt D; Werner P; Raine CS
    Nat Med; 2000 Jan; 6(1):67-70. PubMed ID: 10613826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate excitotoxicity--a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?
    Werner P; Pitt D; Raine CS
    J Neural Transm Suppl; 2000; (60):375-85. PubMed ID: 11205156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
    Kanwar JR; Kanwar RK; Krissansen GW
    Brain; 2004 Jun; 127(Pt 6):1313-31. PubMed ID: 15130951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune encephalomyelitis ameliorated by AMPA antagonists.
    Smith T; Groom A; Zhu B; Turski L
    Nat Med; 2000 Jan; 6(1):62-6. PubMed ID: 10613825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity.
    Takahashi JL; Giuliani F; Power C; Imai Y; Yong VW
    Ann Neurol; 2003 May; 53(5):588-95. PubMed ID: 12730992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation.
    Docagne F; Muñetón V; Clemente D; Ali C; Loría F; Correa F; Hernangómez M; Mestre L; Vivien D; Guaza C
    Mol Cell Neurosci; 2007 Apr; 34(4):551-61. PubMed ID: 17229577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
    Heath PR; Shaw PJ
    Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury.
    Wosik K; Ruffini F; Almazan G; Olivier A; Nalbantoglu J; Antel JP
    Brain; 2004 Dec; 127(Pt 12):2636-48. PubMed ID: 15509624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis and glutamate.
    Groom AJ; Smith T; Turski L
    Ann N Y Acad Sci; 2003 May; 993():229-75; discussion 287-8. PubMed ID: 12853317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The link between excitotoxic oligodendroglial death and demyelinating diseases.
    Matute C; Alberdi E; Domercq M; Pérez-Cerdá F; Pérez-Samartín A; Sánchez-Gómez MV
    Trends Neurosci; 2001 Apr; 24(4):224-30. PubMed ID: 11250007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
    Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
    Wang D; Ayers MM; Catmull DV; Hazelwood LJ; Bernard CC; Orian JM
    Glia; 2005 Aug; 51(3):235-40. PubMed ID: 15812814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord.
    Xu GY; Hughes MG; Ye Z; Hulsebosch CE; McAdoo DJ
    Exp Neurol; 2004 Jun; 187(2):329-36. PubMed ID: 15144859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis.
    Gold BG; Voda J; Yu X; McKeon G; Bourdette DN
    J Neurosci Res; 2004 Aug; 77(3):367-77. PubMed ID: 15248293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition.
    Domercq M; Etxebarria E; Pérez-Samartín A; Matute C
    Glia; 2005 Oct; 52(1):36-46. PubMed ID: 15892126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
    Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
    J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice.
    Onuki M; Ayers MM; Bernard CC; Orian JM
    Microsc Res Tech; 2001 Mar; 52(6):731-9. PubMed ID: 11276125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-mediated excitotoxic axonal damage is attenuated in the absence of myelin proteolipid protein.
    Fowler JH; Edgar JM; Pringle A; McLaughlin M; McCulloch J; Griffiths IR; Garbern JY; Nave KA; Dewar D
    J Neurosci Res; 2006 Jul; 84(1):68-77. PubMed ID: 16625661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.